Edwards Lifesciences (EW) Finished Goods (2010 - 2026)

Edwards Lifesciences has reported Finished Goods for 13 years, with the latest figure at $685.9 million in Q2 2026.

• On a quarterly basis, Finished Goods rose 8.79% year-over-year to $685.9 million in Q2 2026; TTM through Jun 2026 was $685.9 million, a 8.79% increase from a year earlier, with the FY2025 full-year figure at $676.7 million, up 11.04% from the prior year.
• Finished Goods was $685.9 million for Q2 2026 at Edwards Lifesciences, up from $674.4 million in the prior quarter.
• The five-year high for Finished Goods was $685.9 million in Q2 2026, with the low at $511.4 million in Q4 2023.
• Average Finished Goods over 4 years is $623.5 million, with a median of $630.5 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Finished Goods gained 19.16% in 2024, then retreated 11.1% in 2025.
• Over 4 years, Finished Goods stood at $511.4 million in 2023, then increased by 19.16% to $609.4 million in 2024, then advanced by 11.04% to $676.7 million in 2025, then increased by 1.36% to $685.9 million in 2026.
• The last three Finished Goods figures came in at $685.9 million (Q2 2026), $674.4 million (Q1 2026), and $676.7 million (Q4 2025), per Business Quant data.